ISight Therapeutics Revenue
Biotechnology Research • • 1-10 Employees
$
ISight Therapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at ISight Therapeutics
Murugappan Muthukumar
Founder
Company overview
| Headquarters | XX |
| NAICS | 541714 |
| Employees | 1-10 |
About ISight Therapeutics
iSight Therapeutics is commercializing a patented topical treatment for the eye to prevent, intercept, and reverse Cataract formation and Presbyopia without surgery. Most of the global population will develop Cataracts and Presbyopia if they live long enough. iSight Therapeutics is aiming to change their quality of life with its groundbreaking approach.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
ISight Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
ISight Therapeutics has never raised funding before.
Spain
United Kingdom
France
Frequently asked questions
ISight Therapeutics is located in XX.
ISight Therapeutics generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
ISight Therapeutics has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
ISight Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
